PubRank

L G Abood

Author PubWeight™ 44.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Colorimetric Estimation of Succinic Dehydrogenase by Triphenyltetrazolium Chloride. Science 1949 4.77
2 Properties of an ATP-binding protein isolated from membranes of nerve endings. Biochim Biophys Acta 1968 1.59
3 Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol Pharmacol 1978 1.33
4 Purification of the opiate receptor from rat brain. Proc Natl Acad Sci U S A 1981 1.04
5 Electrophysiological, behavioral, and chemical evidence for a noncholinergic, stereospecific site for nicotine in rat brain. J Neurosci Res 1978 1.03
6 Solubilization of the opiate receptor. Life Sci 1980 1.00
7 Cocaine and phencyclidine inhibition of the acetylcholine receptor: analysis of the mechanisms of action based on measurements of ion flux in the millisecond-to-minute time region. Proc Natl Acad Sci U S A 1982 0.95
8 Stereoselective muscarinic acetylcholine and opiate receptiors in human phagocytic leukocytes. Biochem Pharmacol 1980 0.93
9 Interrelationships between phosphates and calcium in bioelectric phenomena. Int Rev Neurobiol 1966 0.93
10 Sites and mechanisms for nicotine's action in the brain. Neurosci Biobehav Rev 1981 0.93
11 Conversion between configurational states of the muscarinic receptor in rat brain. Eur J Pharmacol 1977 0.91
12 Biochemical analysis of isolated bullfrog sarcolemma. Biochim Biophys Acta 1966 0.91
13 Cocaine: mechanism of inhibition of a muscle acetylcholine receptor studied by a laser-pulse photolysis technique. Proc Natl Acad Sci U S A 1995 0.90
14 Stimulation of phospholipase A2 and secretion of catecholamines from brain synaptosomes by potassium and A23187. J Neurochem 1983 0.89
15 Relationship of calcium and phosphates to bioelectric phenomena in the excitatory membrane. Perspect Biol Med 1965 0.87
16 Immunocytochemistry of receptors using anti-idiotypic antibodies. Methods Enzymol 1989 0.85
17 Development of muscarinic cholinergic receptors in inbred strains of mice: identification of receptor heterogeneity and relation to audiogenic seizure susceptibility. Brain Res 1979 0.84
18 Muscarinic cholinergic binding in human erythrocyte membranes. Life Sci 1977 0.84
19 Stereospecific 3H-nicotine binding to intact and solubilized rat brain membranes and evidence for its noncholinergic nature. Life Sci 1980 0.83
20 Preparation and characterization of calcium-binding and other hydrophobic proteins from synaptic membranes. Biochim Biophys Acta 1976 0.82
21 Fluidity in hydrophobic protein regions of synaptic membranes. Eur J Biochem 1974 0.82
22 Uptake and biliary excretion of Cu64 in rabbits in relation to blood ceruloplasmin. Proc Soc Exp Biol Med 1965 0.82
23 Preparation and spectroscopic characterization of molecular species of brain phosphatidylserines. Chem Phys Lipids 1980 0.81
24 Early elevations of glycosidase, acid phosphatase, and acid proteolytic enzyme activity in denervated skeletal muscle. Exp Neurol 1974 0.81
25 In vivo incorporation of l-[14C]serine into phospholipids and proteins of the subcellular fractions of developing rat brain. J Neurochem 1966 0.81
26 [3H]methylcarbamylcholine, a new radioligand for studying brain nicotinic receptors. Biochem Pharmacol 1986 0.80
27 Stereospecific morphine adsorption to phosphatidyl serine and other membranous components of brain. Eur J Pharmacol 1975 0.79
28 Separation of brain phosphatidylserines according to degree of unsaturation by thin-layer chromatography. Anal Biochem 1976 0.79
29 Isolation of a nicotine binding site from rat brain by affinity chromatography. Proc Natl Acad Sci U S A 1983 0.79
30 Carbamate ester latentiation of physiologically active amines. J Med Chem 1970 0.79
31 Phospholipid changes in synaptic membranes by lipolytic enzymes and subsequent restoration of opiate binding with phosphatidylserine. Biochim Biophys Acta 1978 0.78
32 Expression and characterization of the rat alpha 4 beta 2 neuronal nicotinic cholinergic receptor in baculovirus-infected insect cells. J Neurosci Res 1996 0.78
33 Antagonism of nicotine's action by cocaine analogs. Life Sci 1995 0.78
34 [3H]mecamylamine binding to rat brain membranes. Studies with mecamylamine and nicotine analogues. Biochem Pharmacol 1990 0.78
35 Biochemical studies on isolated nerve endings and other particulates of bullfrog brain. Biochim Biophys Acta 1967 0.78
36 Barrel rotation and prostration by vasopressin and nicotine in the vestibular cerebellum. Pharmacol Biochem Behav 1986 0.78
37 Enhancement of stereospecific opiate binding to neural membranes by phosphatidyl serine. Eur J Pharmacol 1976 0.78
38 Opioid receptor antagonist affinity ligands: 6 beta-bromoacetamido-6-desoxynaltrexone and 6 beta-thioglycolamido-6-desoxynaltrexone. Neurochem Res 1992 0.77
39 Differential effect of sodium and potassium on calcium adsorption to stearic acid monolayers. Biochim Biophys Acta 1968 0.77
40 Evidence for a noncholinergic site for nicotine's action in brain: psychopharmacological, electrophysiological and receptor binding studies. Arch Int Pharmacodyn Ther 1979 0.77
41 Two classes of arginine vasopressin binding sites on rat brain membranes. Neurochem Res 1985 0.77
42 14 beta-(2-bromoacetamido)morphine and 14 beta-(2-bromoacetamido)morphinone. J Med Chem 1983 0.77
43 Behavior and receptor changes after kainate lesioning of nodular cerebellum. Pharmacol Biochem Behav 1986 0.76
44 Mechanism of phospholipase A2-induced conduction block in bullfrog sciatic nerve. II. Biochemistry. Brain Res 1986 0.76
45 Nicotine antagonists: phosphoinositide turnover and receptor binding to determine muscarinic properties. Biochem Pharmacol 1989 0.76
46 Chemical requirements of vasopressins for barrel rotation convulsions and reversal by oxytocin. J Neurosci Res 1980 0.75
47 Characterization of a purified nicotinic receptor from rat brain by using idiotypic and anti-idiotypic antibodies. Proc Natl Acad Sci U S A 1987 0.75
48 Molecular characteristics of brain opiate and nicotine receptors. Biomembranes 1983 0.75
49 Action of ATP on the neural tissue-limb deplant of the salamander. Int J Neurosci 1973 0.75
50 Spin-labeled narcotics. Mol Pharmacol 1977 0.75
51 Binding of optically pure (--)-[3H]nicotine to rat brain membranes. FEBS Lett 1983 0.75
52 Solubilization and characterization of muscarinic receptors from bovine brain. Life Sci 1984 0.75
53 4-Bromoacetamidoprocaine: an affinity ligand for brain muscarinic and nicotinic cholinergic receptors. Neurochem Res 1992 0.75
54 Studies on the neural tissue-limb deplant of salamander. Exp Neurol 1969 0.75
55 Investigations on the neural tissue-limb deplant of the salamander. Exp Brain Res 1968 0.75
56 Membrane mechanisms of drugs of abuse. A review of the conference. Prog Clin Biol Res 1979 0.75
57 Selective calcium-alkali metal exchange in a synaptic membrane protein. Experientia 1974 0.75
58 Kinetics of interfacial ATP adsorption and anionic exchange with a synaptic membrane protein. J Neurosci Res 1976 0.75
59 Chemical factors influencing the psychotomimetic potency of glycolate esters. Life Sci 1975 0.75
60 Receptor binding characteristics of a 3H-labeled azetidine analogue of nicotine. Biochem Pharmacol 1987 0.75
61 A psychosis-producing drug as a tool in studying nerve excitation. Recent Adv Biol Psychiatry 1965 0.75
62 Influence of an anticholinergic psychotomimetic agent on behaviour in cats controlled by an auditory stimulus. Neuropharmacology 1974 0.75
63 ATP and other nucleotide interaction with model compounds of amino acids. J Theor Biol 1977 0.75
64 Light absorbance changes in pure mitochondria and other particulates of rat brain. J Neurochem 1966 0.75
65 The action of some CNS and local anesthetic drugs on the stimulated glycolysis of frog sartorius muscle. Int J Neuropharmacol 1966 0.75
66 Mechanism of phospholipase A2-induced conduction block in bullfrog sciatic nerve. I. Electrophysiology and morphology. Brain Res 1986 0.75
67 Differential desensitization of muscarinic receptor-stimulated phosphoinositide turnover in the rat brain. Neurochem Int 1990 0.75
68 Nucleotide content, calcium accumulation, and phosphate metabolism in subcellular fractions of rat brain. Biochim Biophys Acta 1968 0.75
69 Inhibition of phosphoinositide turnover by selective muscarinic antagonists in the rat striatum. Correlation with receptor occupancy. Biochem Pharmacol 1988 0.75
70 Mechanisms of tolerance and dependence: an overview. NIDA Res Monogr 1984 0.75
71 Enhancement of opiate binding by various molecular forms of phosphatidylserine and inhibition by other unsaturated lipids. Biochim Biophys Acta 1977 0.75
72 Probing ion channels and recognition sites of neuronal nicotinic cholinergic receptors with novel nicotine affinity and other ligands. Ann N Y Acad Sci 1995 0.75
73 Ion exchange chromatography of some acidic and aromatic amino acids. J Chromatogr 1966 0.75
74 Stereospecific opiate binding in human erythrocyte membranes and changes in heroin addicts. J Neurosci Res 1976 0.75
75 Comparison of the binding of optically pure (-)- and (+)- [3H]nicotine to rat brain membranes. Neurochem Res 1985 0.75
76 Behavioral and biochemical studies in rats after chronic exposure to nicotine. NIDA Res Monogr 1984 0.75
77 Solubilization and purification of the Ni-stimulated arginine-vasopressin binding site of rat brain membranes. Neurochem Res 1987 0.75
78 Effects of the affinity ligands 14-beta-chloroacetylnaltrexone and 14-beta-bromoacetamidomorphine on [3H]-dihydromorphine binding sites in rat brain. Biochem Pharmacol 1986 0.75
79 Enhancement of opiate binding to neural membranes with an ethyl glycolate ester of phosphatidyl serine. Neurochem Res 1977 0.75
80 Use of phospholipase A to compare phospholipid organization in synaptic membranes, myelin, and liposomes. J Membr Biol 1982 0.75
81 Synthesis and biological characterization of pyridohomotropanes. Structure-activity relationships of conformationally restricted nicotinoids. J Med Chem 1988 0.75
82 Arginine vasopressin-anti-idiotypic immunostaining of human brain cells. J Neuroendocrinol 1990 0.75
83 Synthesis of the first highly potent bridged nicotinoid 9-Azabicyclo[4.2.1]nona[2,3-c]pyridine (pyrido[3,4-b]homotropane). J Am Chem Soc 1986 0.75
84 Phospholipid involvement in the interaction of abused drugs with neural membranes. Prog Clin Biol Res 1979 0.75
85 Effect of calcium and physical state of neutral membranes on phosphatidylserine requirement for opiate binding. Mol Pharmacol 1980 0.75
86 Antagonism by cholinergic drugs of behavioural effects in cats of an anticholinergic psychotomimetic drug and enhancement by nicotine. Neuropharmacology 1977 0.75
87 Acute and chronic effects of nicotine in rats and evidence for a noncholinergic site of action. NIDA Res Monogr 1979 0.75
88 Behavioral effects and binding affinities of two stereoisomeric psychotomimetic glycolates. J Neurosci Res 1976 0.75
89 Effect of calcium, sodium, and aluminum ions on electrical and physical properties of bimolecular lipid membranes. Int J Neurosci 1973 0.75
90 Stereospecific binding of morphine to phosphatidyl serine. Psychopharmacol Commun 1975 0.75
91 Covalent interaction of [3H]-dopamine with rat brain proteins in vivo and with the dopamine-reuptake site of nerve endings in vitro. J Neurosci Res 1981 0.75
92 Mechanism of action of psychotomimetic drugs. Psychopharmacol Bull 1975 0.75
93 Specific binding and metabolism of (-)- and (+)-[3H]-nicotine in isolated rat hepatocytes and hepatocyte membranes. Arch Int Pharmacodyn Ther 1985 0.75
94 Interfacial adsorption of a psychotomimetic drug using liquid scintillation. J Pharm Sci 1973 0.75
95 Inhibition of opiate binding to brain membranes by enzymically inactivated peptidases and tryptic fragments from autolysis. Subst Alcohol Actions Misuse 1980 0.75
96 A benzilate ester of pyrrolizidine and its stereochemical relationship to other psychotomimetic glycolates. Life Sci 1974 0.75
97 Studies on the relationship of binding affinity to psychoactive and anticholingergic potency of a group of psychotomimetic glycolates. Brain Res 1977 0.75
98 Differences in ligand binding and phosphoinositide turnover between M1 muscarinic receptor gene transfected cells and mouse and rat brain membranes. Pharmacol Biochem Behav 1994 0.75
99 Affinity labeling and purification of the opiate receptor from rat brain. Adv Biochem Psychopharmacol 1982 0.75
100 Role of phospholipids in muscarinic binding by neural membranes. Biochem Pharmacol 1977 0.75
101 Synthesis of compounds with potential psychotomimetic activity. IV. J Med Chem 1968 0.75
102 Structure-activity relationships for various N-alkylcarbamyl esters of choline with selective nicotinic cholinergic properties. Biochem Pharmacol 1991 0.75
103 Molecular mechanisms of the brain reward system. NIDA Res Monogr 1996 0.75
104 The biochemical and behavioral effects of phospholipase A2 and morphine microinjections in the periaqueductal gray of the rat. Life Sci 1985 0.75
105 Calcium-adenosine triphosphate-lipid interactions and their significance in the excitatory membrane. Neurosci Res (N Y) 1969 0.75
106 Recent developments in the chemistry and biochemistry of narcotics. IMJ Ill Med J 1966 0.75
107 5-Isothiocyanonicotine: a high-affinity irreversible ligand for brain nicotinic receptors. Biochem Pharmacol 1994 0.75
108 [3H]benzylpempidine, a new radioligand for probing a putative channel site on nicotinic cholinergic receptors. Life Sci 1997 0.75
109 Phencyclidine inhibition of the acetylcholine receptor: measurement of cation flux in a sympathetic neuronal cell line using 22Na+ and spectroscopic detection of Cs+. Arch Biochem Biophys 1983 0.75